Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aclidinium/Formoterol Effects on Pleural Pressures in Smokers
NCT03104634Phase 3Completed
- Sponsor
- McGill University Health Centre
- Start
- May 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aclidinium and formoterol in Lung Hyperinflation (2 arms), sponsored by McGill University Health Centre. Primary endpoint: Inspiratory pleural pressures at rest and throughout incremental exercise at 7 days. Started May 2017; status: completed.
02
Drugs
aclidiniumformoterol
03
Conditions
Lung Hyperinflation
Beyond the preview
Go deeper on NCT03104634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03104634.